September 20, 2026

Asep Darmawan

The Mounting Crisis: Medicaid Work Requirements, Medical Frailty, and the Future of HIV Care in America the-mounting-crisis-medicaid-work-requirements-medical-frailty-and-the-future-of-hiv-care-in-america

The Mounting Crisis: Medicaid Work Requirements, Medical Frailty, and the Future of HIV Care in America

Asep Darmawan July 2, 2026
Introduction On June 1, 2026, the Centers for Medicare and Medicaid Services (CMS) issued an interim final...
Read More Read more about The Mounting Crisis: Medicaid Work Requirements, Medical Frailty, and the Future of HIV Care in America
A New Era for Thyroid Eye Disease: Viridian Therapeutics Challenges Market Incumbent with FDA Approval of Lumvoa a-new-era-for-thyroid-eye-disease-viridian-therapeutics-challenges-market-incumbent-with-fda-approval-of-lumvoa

A New Era for Thyroid Eye Disease: Viridian Therapeutics Challenges Market Incumbent with FDA Approval of Lumvoa

Asep Darmawan June 30, 2026
By Delilah Alvarado Published June 30, 2026 The landscape for the treatment of thyroid eye disease (TED)...
Read More Read more about A New Era for Thyroid Eye Disease: Viridian Therapeutics Challenges Market Incumbent with FDA Approval of Lumvoa
Unraveling the Link Between Primary Glomerulonephritis and Anemia: A Turkish Study Sheds New Light unraveling-the-link-between-primary-glomerulonephritis-and-anemia-a-turkish-study-sheds-new-light

Unraveling the Link Between Primary Glomerulonephritis and Anemia: A Turkish Study Sheds New Light

Asep Darmawan June 28, 2026
A comprehensive study from Turkey has delved into the intricate relationship between primary glomerulonephritis (PGN) and anemia,...
Read More Read more about Unraveling the Link Between Primary Glomerulonephritis and Anemia: A Turkish Study Sheds New Light
Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup pfizers-sigvotatug-vedotin-fails-to-meet-primary-endpoint-in-previously-treated-nsclc-trial-but-shows-promise-in-subgroup

Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup

Asep Darmawan June 25, 2026
New York, NY – [Date of Publication] – Pfizer has announced topline results from its pivotal Phase...
Read More Read more about Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup

You may have missed

the-architecture-of-resilience-how-one-mans-story-defines-the-heart-of-san-franciscos-hiv-community

The Architecture of Resilience: How One Man’s Story Defines the Heart of San Francisco’s HIV Community

Neng Nana September 20, 2026
the-great-insurance-debate-dissecting-the-role-of-health-insurers-in-americas-fiscal-crisis

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Muslim September 20, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution-2

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Lina Hope September 20, 2026
salk-scientists-unveil-estrogen-related-receptors-as-key-to-unlocking-energy-metabolism-and-combating-muscle-fatigue

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

Ammar Sabilarrohman September 20, 2026